Tag: CNS Pharmaceutical Inc. (NASDAQ: CNSP)


WPD Pharmaceuticals Inc (OTCMKTS: WPDPF) Announces that CNS Pharmaceuticals Inc (NASDAQ: CNSP) has Received FDA Fast Track Label for Berubicin

WPD Pharmaceuticals Inc (OTCMKTS: WPDPF) announced that CNS Pharmaceuticals Inc (NASDAQ: CNSP) received a Fast Track Designation from the U.S. Food and Drug Administration (FDA) for its investigational lead drug, Berubicin. Designation permits company to frequent interactions with FDA Berubicin is used for the management of patients with recurring glioblastoma […]


CNS Pharmaceutical Inc. (NASDAQ: CNSP) Offers Updates On Development of Berubicin in Treating GBM

CNS Pharmaceutical Inc. (NASDAQ: CNSP) announced its business update, including the recent launch of a pivotal study of its flagship program assessing Berubicin in adult Glioblastoma Multiforme (FB) treatment and expects to commence dosing in Q3 2021.¬† Berubicin receives Fast Track Designation¬† The company received Fast track Designation for Berubicin […]